Early C-reactive protein as a predictive biomarker for postoperative complications following robot-assisted surgery for rectal cancer - Quiz - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

C-reactive protein measured early as a prognostic indicator for postoperative complications after robot-assisted rectal cancer surgery

  • By

  • Fuminori Teraishi

  • Ryusei Takahashi

  • Hiroki Okabayashi

  • Masashi Utsumi

  • Hideaki Miyaso

  • Ryohei Shoji

  • Toshiyoshi Fujiwara

  • Toshiharu Mitsuhashi

  • Masaru Inagaki

  • August 28, 2025

Share

Original Source(s)

Early C-reactive protein as a predictive biomarker for postoperative complications following robot-assisted surgery for rectal cancer

  • by Fuminori Teraishi, Ryusei Takahashi, Hiroki Okabayashi, Masashi Utsumi, Hideaki Miyaso, Ryohei Shoji, Toshiyoshi Fujiwara, Toshiharu Mitsuhashi, Masaru Inagaki

  • August 28, 2025

Related Content

Retrorectal Surgery Linked to Low Recurrence

A 25-year tertiary center cohort reports high recurrence-free survival following surgery and suggests preoperative biopsy should be used selectively.

Neoadjuvant Chemo Did Not Improve Disease-Free Survival

Phase 3 NeoCol trial adds to mixed evidence as field shifts toward biomarker-guided approaches

1-L Prep Boosts Quality, Not Adequacy

Randomized trial in hospitalized patients found improved high-quality bowel cleansing with 1-L regimen, though primary endpoint differences were not statistically significant